Persistent Morbillivirus Infection Leads to Altered Cortactin Distribution in Histiocytic Sarcoma Cells with Decreased Cellular Migration Capacity

PLoS One. 2016 Dec 2;11(12):e0167517. doi: 10.1371/journal.pone.0167517. eCollection 2016.

Abstract

Histiocytic sarcomas represent rare but fatal neoplasms in humans. Based on the absence of a commercially available human histiocytic sarcoma cell line the frequently affected dog displays a suitable translational model. Canine distemper virus, closely related to measles virus, is a highly promising candidate for oncolytic virotherapy. Therapeutic failures in patients are mostly associated with tumour invasion and metastasis often induced by misdirected cytoskeletal protein activities. Thus, the impact of persistent canine distemper virus infection on the cytoskeletal protein cortactin, which is frequently overexpressed in human cancers with poor prognosis, was investigated in vitro in a canine histiocytic sarcoma cell line (DH82). Though phagocytic activity, proliferation and apoptotic rate were unaltered, a significantly reduced migration activity compared to controls (6 hours and 1 day after seeding) accompanied by a decreased number of cortactin mRNA transcripts (1 day) was detected. Furthermore, persistently canine distemper virus infected DH82 cells showed a predominant diffuse intracytoplasmic cortactin distribution at 6 hours and 1 day compared to controls with a prominent membranous expression pattern (p ≤ 0.05). Summarized, persistent canine distemper virus infection induces reduced tumour cell migration associated with an altered intracellular cortactin distribution, indicating cytoskeletal changes as one of the major pathways of virus-associated inhibition of tumour spread.

MeSH terms

  • Animals
  • Cell Line, Tumor
  • Cell Movement*
  • Cortactin / biosynthesis*
  • Distemper / metabolism*
  • Distemper / pathology
  • Distemper Virus, Canine / metabolism*
  • Dogs
  • Gene Expression Regulation, Neoplastic*
  • Histiocytic Sarcoma / metabolism*
  • Histiocytic Sarcoma / pathology
  • Histiocytic Sarcoma / virology
  • Humans
  • Neoplasm Proteins / biosynthesis*

Substances

  • Cortactin
  • Neoplasm Proteins

Grants and funding

VMP was financially supported by the Akademie für Tiergesundheit e. V. (Bonn, Germany; http://www.aft-online.net/home/die-akademie/). MSA received financial support from the Ministry of Higher Education (Cairo, Egypt). WBA and RU: This study was in part supported by the German Research Foundation (Researcher’s group 1103; grants BA815/10-2 and UL421/1-2 (http://www.dfg.de/). WBA: This study was in part supported by the Gesellschaft zur Förderung Kynologischer Forschung e.V (GkF, Bonn, Germany; https://www.gkf-bonn.de/index.php/startseite.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.